Serge Jabbour
- Endocrinology, Diabetes and Metabolism top 0.5%
- Molecular Biology top 10%
- Surgery top 5%
- Pharmacology top 2%
- Epidemiology top 10%
- Co-authors
- Elise HardyCristian GujaJuan P. FríasAzazuddin AhmedPeter ÖhmanJulio RosenstockB. J. GoldsteinMarie‐Louise Hartoft‐Nielsen
- Topics
- Diabetes Treatment and Management (37 papers)Metabolism, Diabetes, and Cancer (23 papers)Diabetes Management and Research (22 papers)
- Journals
- JAMAGastroenterologyDiabetes Care
- Partner nations
- United StatesRomaniaUnited Kingdom
In The Last Decade
Serge Jabbour
74 papers receiving 2.9k citations
Hit Papers
Peers
Comparison fields: 5 of 122
- Endocrinology, Diabetes and Metabolism 2.3k
- Molecular Biology 1.1k
- Surgery 896
- Pharmacology 428
- Epidemiology 317
Countries citing papers authored by Serge Jabbour
This map shows the geographic impact of Serge Jabbour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Serge Jabbour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Serge Jabbour more than expected).
Fields of papers citing papers by Serge Jabbour
This network shows the impact of papers produced by Serge Jabbour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Serge Jabbour. The network helps show where Serge Jabbour may publish in the future.
Co-authorship network of co-authors of Serge Jabbour
This figure shows the co-authorship network connecting the top 25 collaborators of Serge Jabbour. A scholar is included among the top collaborators of Serge Jabbour based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Serge Jabbour. Serge Jabbour is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 4 | |
| 4 | 0 | |
| 5 | 7 | |
| 6 | 77 | |
| 7 | 3 | |
| 8 | Safety update on dapagliflozin (DAPA) across the phase 2b/3 clinical trial program | 2 |
| 9 | Exenatide once weekly plus dapagliflozin once daily versus exenatide or dapagliflozin alone in patients with type 2 diabetes inadequately controlled with metformin monotherapy (DURATION-8): a 28 week, multicentre, double-blind, phase 3, randomised controlled trialbreakdown → | 328 |
| 10 | 12 | |
| 11 | 4 | |
| 12 | 56 | |
| 13 | 9 | |
| 14 | 5 | |
| 15 | 15 | |
| 16 | 9 | |
| 17 | 10 | |
| 18 | 119 | |
| 19 | 6 | |
| 20 | 4 |
About Serge Jabbour
Serge Jabbour is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Pharmacology, having authored 78 papers that have together received 3.0k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (37 papers), Metabolism, Diabetes, and Cancer (23 papers) and Diabetes Management and Research (22 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (2.3k citations), Pharmacology (428 citations) and Surgery (896 citations). Serge Jabbour has collaborated with scholars based in United States, Romania and United Kingdom. Frequent co-authors include Elise Hardy, Cristian Guja, Juan P. Frías, Azazuddin Ahmed, Peter Öhman, Julio Rosenstock, B. J. Goldstein, Marie‐Louise Hartoft‐Nielsen, Melanie J. Davies and Thomas R. Pieber. Their work appears in journals such as JAMA, Gastroenterology and Diabetes Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.